To look more closely at the implications of COQ2 mutations on mitochondrial function, Nakamoto and colleagues reprogrammed peripheral blood mononuclear cells from patient with a compound heterozygous COQ2 mutation, an idiopathic MSA patient, and three control lines of diverse descent (Caucasian, African, and Japanese origin). This evidence concerns the gene COQ2 and multiple system atrophy.